Skip to main content

AlphaCentric Advisors LLC

SEC CIK
0001913464
Latest filing
Jul 24, 2026

TRVI holding history

Trevi Therapeutics, Inc. in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TRVI overviewAll 13F holders of TRVIFull Q2 2026 holdings

Shares (Q2 2026)
24,317
Value
$453.5K
% of portfolio
0.4%
Quarters held
3
Since Q4 2025
Holdings of TRVI by AlphaCentric Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202624,317$453.5K0.4%+347+1.4%AddedHolders
Q1 202623,970$286.0K0.3%+1,303+5.7%AddedHolders
Q4 202522,667$283.8K0.3%–No prior filingHolders